BTIG Downgrades Protagonist Therapeutics(PTGX.US) to Hold Rating, Raises Target Price to $67

Moomoo News12:32 ET · Ratings

Natural Grocers By Vitamin Cottage, Elastic, Matthews International, Gap And Other Big Stocks Moving Higher On Friday

BenzingaNov 22 10:59 ET

Wedbush Maintains Protagonist Therapeutics(PTGX.US) With Buy Rating, Maintains Target Price $58

Moomoo NewsNov 22 07:31 ET · Ratings

Protagonist Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Conference 2024

AccesswireNov 22 07:30 ET

Protagonist Therapeutics Price Target Raised to $67 From $51 at BTIG

TipRanksNov 22 07:25 ET

Protagonist Therapeutics Price Target Maintained With a $50.00/Share by HC Wainwright & Co.

Dow JonesNov 22 07:06 ET · Ratings